Lupin acquires Southern Cross Pharma in Australia Medical Dialogues Bureau31 July 2021 1:21 PM ISTLupin said as a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million...
CDSCO flags 39 drug samples including Aspirin, Remdesivir as not of standard quality Medical Dialogues Team31 July 2021 12:45 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has flagged 39...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 6:21 PM ISTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving...
India among top 10 countries in pharma, healthcare: Sagacious IP Report Ruchika Sharma27 July 2021 12:21 PM ISTNew Delhi: India is among the top 10 countries in pharma and healthcare sector with exponential growth recorded in the last five years, according to a...
Lupin launches generic equivalent of Kerydin Topical Solution in US Ruchika Sharma14 July 2021 11:30 AM ISTMumbai: Global pharma major, Lupin Limited, has announced the US launch of Tavaborole Topical Solution, 5% having received an approval from the United...
Lupin gets CDSCO committee approval for marketing Ranibizumab Medical Dialogues Team7 July 2021 5:03 PM ISTNew Delhi: In a major rejoice to drug maker Lupin, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has...
Lupin gets USFDA nod to expand Solosec use for Trichomoniasis Ruchika Sharma2 July 2021 1:00 PM ISTBaltimore: Pharma major, Lupin Pharmaceuticals, has recently announced that the U.S. Food and Drug Administration (FDA) has approved the company's...
Lupin bags USFDA nod for Dolutegravir, Lamivudine, Tenofovir Disoproxil Fumarate Tablets under PEPFAR Ruchika Sharma30 Jun 2021 5:13 PM ISTMumbai: Global pharma major, Lupin Limited, today announced that the company has received tentative approval from the United States Food and Drug...
Bajaj Healthcare moves patent office after Eli Lilly refuses to ink Baricitinib agreement Medical Dialogues Team28 Jun 2021 5:45 PM ISTNew Delhi: With Eli Lilly denying to ink voluntary licensing agreement for Baricitinib, Bajaj Healthcare Ltd (BHL) has approached the Indian patent...
NPPA fixes retail price of 3 formulations including HIV, Oncology drug Medical Dialogues Team20 Jun 2021 11:30 AM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Lupin gets USFDA nod for generic equivalent of Renagel Tablets Ruchika Sharma18 Jun 2021 12:45 PM ISTSevelamer Hydrochloride Tablets are indicated for the control of serum phosphorous in patients with chronic kidney disease (CKD) on dialysis.
Lupin gets CDSCO panel nod for phase III trial of Formoterol Fumarate, Budesonide FDC Medical Dialogues Team17 Jun 2021 12:30 PM ISTNew Delhi: Pharmaceutical major, Lupin has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
